Pancreas and islet transplantation for patients with diabetes.
The DOI matches its Crossref record.
Abstract
Hi s t o r i c a l l y, patients with diabetes have expended tremendous eff o rt in pursuing a re t u rn to norm o g l y c e m i a . The relatively recent results of the Diabetes C o n t rol and Complications Trial (DCCT), demonstrating an approximate 50% re d u ction in eye, nerve, and kidney complications in a group of patients re c e i v i n g intensive treatment for hyperglycemia (1), have made this pursuit even more intense. Successful pancreas and islet transplantations are currently the only therapies that re p roducibly achieve normoglycemia by reestablishing endogenous insulin secretion responsive to normal feedback re g u l ation. This re p o rt briefly considers the h i s t o ry, techniques, clinical results, and risk-benefit relationship of successful panc reas and pancreatic islet transplantations in hyperglycemic patients with long-standing diabetes. PANCREAS T R A N S P L A N TAT I O N — P a n c re a t i c transplantation was first used for the tre a tment of type 1 diabetes in humans in 1966 (2). In that early era, the rates of graft and patient survival were low, so very few proc e d u res were perf o rmed until 1978. Important steps toward improving surgical re s u l t s included the introduction of impro v e d i m m u n o s u p p ressive regimens, especially the use of cyclosporine and anti‐T- c e l l agents, new surgical techniques, and the selection of healthier recipients. In the past decade, the number of pro c e d u res perf o rmed has steadily increased each year (3). By the end of 1997, nearly 10,000 panc reatic transplantations had been re c o rd e d in the International Pancreas Tr a n s p l a n t R e g i s t ry, and in that year alone, more than 1,200 pro c e d u res were re p o rted. The results from diff e rent centers vary depending on operative experience and patient selection. The 1994‐1997 data from the I n t e rnational Pancreas Transplant Registry (3) indicate an overall 1-year patient survival rate of 90% (Fig. 1). The 1-year rate of graft survival (defined as total fre e d o m f rom insulin therapy, normal fasting blood glucose concentrations, and normal or only slightly elevated HbA 1 c values) was 82% when a pancreas and a kidney were transplanted simultaneously (SPK), 71% when a p a n c reas was transplanted after kidney transplantation (PAK), and 62% when a p a n c reas was transplanted alone (PTA ) . Most pancreatic transplantations in diabetic patients with renal failure are perf o rmed at the same time as or after kidney transplantation. The objectives in this instance are to render the patient free of exogenous insulin therapy, to arrest the p ro g ress of ongoing secondary complications, to protect the transplanted kidney f rom hyperglycemia, and to improve quality of life. In unusual circumstances, the p a n c reas is transplanted alone, but the decision to do so is more difficult. In these patients, kidney transplantation and i m m u n o s u p p ression are not already indicated, and survival of pancreas grafts when transplanted alone is lower than when transplanted simultaneously with a kidn e y. Inclusion criteria for PTA include that the patient is severely metabolically unstable, has severe autonomic dysfunction, or generally has a very poor quality of life because of the effects of chronic diabetes. Although the success rate of PTA is lower, this may be due to the lack of a marker for p a n c reas rejection that is as sensitive as s e rum creatinine is as a marker for kidney transplant rejection. Hence, rejection is m o re difficult to detect and anti-re j e c t i o n t reatment is initiated later. Technique
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683
“However, -cell replacement by transplantation (whole pancreas or islet transplantation) has limitations as a therapy for diabetes (9,10).”
BackgroundTHE IMPACT OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION ON LONG-TERM PATIENT SURVIVAL1
Ojo, A. O., Meier-Kriesche, H.-U., Hanson, J. A., Leichtman, A., Magee, J. C., Cibrik, D., Wolfe, R. A., Port, F. K., Agodoa, L., Kaufman, D. B., et al. (2001) · Transplantation · doi:10.1097/00007890-200101150-00014 · Cited by 362
Considerations for successful transplantation of encapsulated pancreatic islets
de Vos, P., Hamel, A. F., & Tatarkiewicz, K. (2002) · Diabetologia · doi:10.1007/s00125-001-0729-x · Cited by 252
Pancreas transplantation in type 1 diabetes
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s105 · Cited by 85
Speight, J., Reaney, M. D., Woodcock, A. J., Smith, R. M., & Shaw, J. A. M. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03029.x · Cited by 64
Metadata
- Authors
- Robertson, R. P., Davis, C., Larsen, J., Stratta, R., & Sutherland, D. E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2000-01-01
- Volume
- 23
- Issue
- 1
- Pages
- 112-116
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2106046975
- Cited by
- 132
- References
- 0
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pancreas and islet transplantation for patients with diabetes. https://app.cochat.ai/papers/10.2337/diacare.23.1.112
- The paper
- Robertson, R. P., Davis, C., Larsen, J., Stratta, R., & Sutherland, D. E. (2000). Pancreas and islet transplantation for patients with diabetes. Diabetes Care. https://doi.org/10.2337/diacare.23.1.112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.